Relevant bibliographies by topics / Poliomyelitis – Prevention

Academic literature on the topic 'Poliomyelitis – Prevention'

Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Contents

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Poliomyelitis – Prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Poliomyelitis – Prevention"

1

HENNEKENS, CHARLES, and JULIE E. BURING. "Need for Large Sample Sizes in Randomized Trials." Pediatrics 79, no. 4 (April 1, 1987): 569–71. http://dx.doi.org/10.1542/peds.79.4.569.

Full text
Abstract:
Prevention is an area of relevance and concern to all health professionals, in particular, pediatricians. This concept encompasses primary prevention of disease (such as diphtheria, pertussis, tetanus, and poliomyelitis) among healthy individuals as well as secondary prevention or the reduction in risks of complications, recurrences, or mortality among those already affected. It is unlikely that a new measure will have as dramatic an effect as did the poliomyelitis vaccine, a prevention measure, which reduced the incidence of paralytic disease in the vaccinated group more than 50% compared with children given placebo. Analogously, virtually none of the new therapeutic measures of promise is likely to have as clear-cut an effect as did penicillin, which decreased mortality from pneumococcal pneumonia approximately sixfold (from about 95% to 15%).
APA, Harvard, Vancouver, ISO, and other styles
2

Larin, V. F., L. I. Zhukova, V. V. Lebedev, and G. K. Rafeyenko. "INTERFERENCE INTERACTION OF VIRUSES IN THE REGULATION OF AN EPIDEMIC PROCESS." Epidemiology and Infectious Diseases 17, no. 1 (February 15, 2012): 25–29. http://dx.doi.org/10.17816/eid40639.

Full text
Abstract:
A long-term trend in the incidence of viral hepatitis A (VHA) in relation to vaccine prevention of this disease and poliomyelitis were analyzed in the Krasnodar Territory. There were lower VHA morbidity rates, which coincided with the period of additional mass immunization of children against poliomyelitis. Comparison of the frequency of polio vaccination and the trend in VHA incidence suggests that the viral interference phenomenon is involved in the regulation of its epidemic process, as a result of which vaccine poliomyelitis virus suppresses naturally circulating hepatitis virus A.
APA, Harvard, Vancouver, ISO, and other styles
3

Chernyshova, L. I. "Strategic directions for the prevention of poliomyelitis (lecture)." SOVREMENNAYA PEDIATRIYA, no. 5(69) (September 30, 2015): 14–17. http://dx.doi.org/10.15574/sp.2015.69.14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Wright, Peter F., and David T. Karzon. "Minimizing the Risks Associated with the Prevention of Poliomyelitis." New England Journal of Medicine 332, no. 8 (February 23, 1995): 529–30. http://dx.doi.org/10.1056/nejm199502233320809.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

RIDGWAY, D. "The logic of causation and the risk of paralytic poliomyelitis for an American child." Epidemiology and Infection 124, no. 1 (February 2000): 113–20. http://dx.doi.org/10.1017/s0950268899003350.

Full text
Abstract:
Beginning in January 1997, American immunization policy allowed parents and physicians to elect one of three approved infant vaccination strategies for preventing poliomyelitis. Although the three strategies likely have different outcomes with respect to prevention of paralytic poliomyelitis, the extreme rarity of the disease in the USA prevents any controlled comparison. In this paper, a formal inferential logic, originally described by Donald Rubin, is applied to the vaccination problem. Assumptions and indirect evidence are used to overcome the inability to observe the same subjects under varying conditions to allow the inference of causality from non-randomized observations. Using available epidemiologic information and explicit assumptions, it is possible to project the risk of paralytic polio for infants immunized with oral polio vaccine (1·3 cases per million vaccinees), inactivated polio vaccine (0·54 cases per million vaccinees), or a sequential schedule (0·54–0·92 cases per million vaccinees).
APA, Harvard, Vancouver, ISO, and other styles
6

Liu, Xiaoyi, and Tianchen Yao. "The Intervention and treatment of the Poliomyelitis." Highlights in Science, Engineering and Technology 8 (August 17, 2022): 256–62. http://dx.doi.org/10.54097/hset.v8i.1142.

Full text
Abstract:
Polio comes from a wild polio-virus that infects children and has a high mortality rate. Once infected, there is no cure. So in the face of polio, more attention is paid to prevention measures and the follow-up treatment of survivors of polio disease. It covers the background to polio, the international response, and what has been achieved over the years in polio control. Polio prevention is divided into a vaccine component and daily protection, with the Inactivated polio vaccine (IPV) and Oral polio vaccine (OPV), OPV being an oral vaccine and IPV requiring a medical professional to administer it. The two are most effective when used together. Next is the daily protection, such as isolating close contacts and paying attention to human hygiene, etc. For the follow-up treatment of polio survivors that is, post-poliomyelitis patients. A variety of methods are used in this treatment, and the final clinical results show that non-pharmacologic treatment is more conducive to improving patients' lives and active treatment.
APA, Harvard, Vancouver, ISO, and other styles
7

Celebi, G., R. Kurt, and V. Lok. "PREVENTION OF NEUROVASCULAR COMPLICATIONS IN EXTENSION OSTEOTOMY OF THE TIBIA IN POLIOMYELITIS." Journal of Pediatric Orthopaedics 11, no. 6 (November 1991): 814. http://dx.doi.org/10.1097/01241398-199111000-00070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Celebi, G., R. Kurt, V. Lok, A. Sebik, E. Barin, and B. Zeren. "Prevention of neurovascular complications in extension osteotomy of the tibia in poliomyelitis." International Orthopaedics 15, no. 1 (April 1991): 29–30. http://dx.doi.org/10.1007/bf00210529.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Plotkin, Stanley A. "Developed countries should use inactivated polio vaccine for the prevention of poliomyelitis." Reviews in Medical Virology 7, no. 2 (July 1997): 75–81. http://dx.doi.org/10.1002/(sici)1099-1654(199707)7:2<75::aid-rmv192>3.0.co;2-o.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Henderson, D. A. "Developed countries shouldnot use inactivated polio vaccine for the prevention of poliomyelitis." Reviews in Medical Virology 7, no. 2 (July 1997): 83–86. http://dx.doi.org/10.1002/(sici)1099-1654(199707)7:2<83::aid-rmv193>3.0.co;2-q.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Poliomyelitis – Prevention"

1

"Algorithms and computational complexity of social influence and diffusion problems in social networks." 2015. http://repository.lib.cuhk.edu.hk/en/item/cuhk-1291255.

Full text
Abstract:
Since diffusion models of social network are widely used in studying epidemiology, in this thesis, we apply diffusion models to study the contact immunity generated by attenuated vaccines.Oral polio vaccine (OPV) is a typical attenuated vaccine for polio that can produce contact immunity and therefore help protect more individuals than vaccinees.
To better capture the utilization of OPV’s contact immunity, we model the community as a social network, and formulate the task of maximizing the contact immunity effect as an optimization problem on graphs, which is to find a sequence of vertices to be “vaccinated” to maximize the total number of vertices “infected” by the attenuated virus. Furthermore, as immune defiicient patients may suffer from the live attenuated virus in the vaccine, we develop models in consideration of this restriction, and study related problems.
We present polynomial-time algorithms for these problems on trees, and show the intractability of problems on general graphs.
社交網絡的擴散模型被廣泛運用于對流行病學的研究，在本文中，我們使用擴散模型對減毒活疫苗產生的接觸性免疫進行研究。口服脊髓灰質炎疫苗（OPV）是一種典型的減毒活疫苗，它可以在人群中產生接觸性免疫，使得更多未接種疫苗的人獲得免疫力。
爲了更好的刻畫OPV 產生的接觸性免疫，我們將社區模型化為社交網絡，從而將接觸性免疫效應最大化的任務轉化爲圖優化問題，即通過發現頂點的一個「接種」序列來最大化被減活病毒「感染」的頂點數量。此外，因爲減毒疫苗中的活病毒會使患有免疫缺陷的病人患病，我們考慮在此因素限制下的模型，并研究相關的問題。
我們給出這些問題在樹上的多項式時間算法，并證明其在一般圖上的複雜性。
Ma, Chenglong.
Thesis M.Phil. Chinese University of Hong Kong 2015.
Includes bibliographical references (leaves 40-47).
Abstracts also in Chinese.
Title from PDF title page (viewed on 12, September, 2016).
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
Detailed summary in vernacular field only.
APA, Harvard, Vancouver, ISO, and other styles

Books on the topic "Poliomyelitis – Prevention"

1

Services, Namibia Ministry of Health and Social. National polio eradication: Plan of action. [Windhoek]: The Ministry, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Fiore, Stefano, Lucia Fiore, and Gabriele Buttinelli. Sorveglianza delle paralisi flaccide acute e della circolazione ambientale di poliovirus e altri enterovirus in Italia. Roma: Istituto superiore di sanità, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Polio eradication and its discontents: An historian's journey through an international public health (un)civil war. New Delhi: Orient Blackswan, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

A tale of two drops. New Delhi: Ocean Books, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

World Health Organization. Regional Office for Africa. Progress report on the Polio Eradication Initiative in the African region, 1996/97. Belvedere, Harare, Zimbabwe: The Office, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Hyde, Karin A. L. Malaŵi Against Polio programme evaluation: Final report. [Zomba, Malawi]: University of Malaŵi, Centre for Social Research, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Development, United States Agency for International. The USAID polio eradication initiative: 1998 report to Congress. Arlington, Va: Center for International Health Information, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Global eradication of polio and measles: Hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, second session, special hearing. Washington: U.S. G.P.O., 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Salgado, Sebastião. The end of polio: A global effort to end a disease. Boston: Bulfinch, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

West Bengal Board of Madrasah Education. Polio-Cell. Polio documentation. Kolkata: West Bengal Board of Madrasah Education, 2004.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Poliomyelitis – Prevention"

1

GS, Kulkarni. "Chapter-062 Acute Poliomyelitis and Prevention." In Textbook of Orthopaedics &amp Trauma Vol 1, 511–17. Jaypee Brothers Medical Publishers (P) Ltd., 2008. http://dx.doi.org/10.5005/jp/books/10938_62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Agarwal, AK. "Chapter-03 Poliomyelitis: Etiology, Clinical Course, Prevention and Rehabilitation." In Essentials of Prosthetics and Orthotics, 15–21. Jaypee Brothers Medical Publishers (P) Ltd, 2013. http://dx.doi.org/10.5005/jp/books/11794_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

William Tong, C. Y. "Vaccine-Preventable Diseases." In Tutorial Topics in Infection for the Combined Infection Training Programme. Oxford University Press, 2019. http://dx.doi.org/10.1093/oso/9780198801740.003.0024.

Full text
Abstract:
These are diseases in which an effective preventive vaccine exists. A death that could have been prevented by vaccination is a vaccine- preventable death. The World Health Organization (WHO) has identified twenty-five diseases as vaccine preventable. This list may expand as new vaccines are being developed. The Expanded Programme on Immunization, or EPI, is vaccination programme introduced in 1974 by the WHO to all nations. The EPI initially targeted diphtheria, whooping cough, tetanus, measles, poliomyelitis, and tuberculosis. The aim was to provide universal immunization for all children by 1990 and to achieve health for all by 2000. In 2010, about 85% of children under one year of age in the world had received at least three doses of DTP vaccine (diphtheria, tetanus, and polio). Additional vaccines have now been added to the original six targets. Most countries have now added Hepatitis B (not in UK) and Haemophilus influenzae type b (Hib) to their routine infant immunization schedules, and an increasing number are in the process of adding pneumococcal conjugate vaccine and rotavirus vaccines to their schedules. Immunization is a proven tool for controlling and even eradicating infectious diseases. The immunization campaign against smallpox between 1967 and 1977 resulted in the eradication of smallpox. Apart from smallpox, the only other viral infection that was declared eradicated through vaccination campaign was rinderpest in cattle (2011), a close relative of measles virus in humans. Another major infection target for global eradication is against poliomyelitis—the global polio eradication initiative (GPEI). When the programme began in 1988, polio threatened 60% of the world’s population. Eradication of poliomyelitis is now within reach: infections have fallen by 99%; wild type polio type 2 was last detected in 1999 and declared eradicated in 2015; wild-type poliovirus type 3 has not been detected in the world since 2012. Poliovirus type 1 is the only wild- type virus in circulation and endemic transmission is only reported in Afghanistan and Pakistan. Currently, the old trivalent oral poliovirus vaccine is replaced by the more potent bivalent poliovirus type 1 and 3 vaccine. Many western countries have switched from oral vaccine to the injected inactivated vaccine to avoid the problem of vaccine- induced paralysis, which could be associated with the oral live attenuated vaccine.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Poliomyelitis – Prevention' for particular source types:
Journal articles Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography